Physician profile
Ryan D Severo
NPI 1952922502
$3,502.53
in general payments reported to CMS, 2019-2025
36 companies · $727 in 2025
The $727 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $684 · 2023: $944 · 2024: $814 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,484.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $496.72 | 2022-2025 | Rybelsus, Ozempic, Tresiba |
| Abbvie INC. | $452.47 | 2022-2025 | |
| Amgen INC. | $348.23 | 2021-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $338.77 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $200.57 | 2021-2024 | |
| Lilly USA, LLC | $188.17 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Exact Sciences Corporation | $185.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $171.60 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $146.26 | 2021-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $138.23 | 2021-2025 | Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $66.93 | 2022-2024 | Gardasil 9, Gardasil, Pneumovax 23 |
| Otsuka America Pharmaceutical, INC. | $56.79 | 2023 | Rexulti |
| Alnylam Pharmaceuticals INC. | $54.24 | 2024 | Onpattro |
| Mallinckrodt Hospital Products INC. | $53.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $51.40 | 2024 | Xarelto |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Severo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.